Deutsch
 
Benutzerhandbuch Datenschutzhinweis Impressum Kontakt
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm

MPG-Autoren

Chmielecki,  Juliann
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

/persons/resource/persons147255

Peifer,  Martin
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Viale,  Agnes
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Hutchinson,  Katherine
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Giltnane,  Jennifer
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Socci,  Nicholas D.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Dean,  Rebecca S.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Yenamandra,  Ashwini
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Jagasia,  Madan
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Kim,  Annette S.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Davé,  Utpal P.
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

/persons/resource/persons147315

Thomas,  Roman K.
Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

Pao,  William
a Weill Cornell Graduate School of Medical Sciences, New York, NY b Genomics Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY c Department of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232 d Vanderbilt University Medical Center, Nashville, TN e Bioinformatics Core, Memorial Sloan-Kettering Cancer Center, New York, NY f Department I of Internal Medicine and Center of Integrated Oncology Köln-Bonn, University of Cologne, Köln, Germany g Chemical Genomics Center of the Max Planck Society, Dortmund, Germany;

Externe Ressourcen
Es sind keine Externen Ressourcen verfügbar
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Chmielecki, J., Peifer, M., Viale, A., Hutchinson, K., Giltnane, J., Socci, N. D., et al. (2012). Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm. Genes Chromosomes and Cancer, 51(1), 54-65. doi:10.1002/gcc.20930.


Zitierlink: http://hdl.handle.net/11858/00-001M-0000-0026-D996-F
Zusammenfassung
© 2011 Wiley-Liss, Inc.